About Cynthia Chmielewski

Articles by Cynthia Chmielewski

What are Antibodies and How are They Used in Multiple Myeloma?
May 31, 2024
MRD as a Clinical Trial Endpoint: A Patient Perspective
Apr 22, 2024
Diferentes Tipos de Células CAR-T en el Mieloma Múltiple
Apr 15, 2024
Efectos Secundarios de las Células CAR-T
Apr 09, 2024
Terminología de las Células CAR-T
Mar 25, 2024
Administración de Células NK (Natural Killer)
Jan 16, 2024
¿Qué Son las Células Natural Killer?
Jan 08, 2024
December Traditions- #ASH23 from a Myeloma Patient’s Point of View
Dec 05, 2023
Esperanza en el mieloma múltiple
Jun 22, 2023
ASCO 2023: The New T-Charged CAR on the Block: PHE885
Jun 06, 2023
A New Bi-Specific Antibody Therapy On The Horizon: ABBV-383
Jun 01, 2023
Venetoclax For Multiple Myeloma
May 24, 2023
Mezigdomide - Therapies On The Horizon
May 16, 2023
Elranatamab - Therapies On The Horizon
May 09, 2023
What You Need to Know About Starting Myeloma Treatment
May 02, 2023
Observación del ratio de cadenas ligeras libres para determinar la progresión del mieloma latente a mieloma activo
Mar 28, 2023
Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal
Mar 21, 2023
All About TECVAYLI (Teclistamab)
Mar 14, 2023
All About IVIG (Intravenous Immunoglobulin)
Mar 08, 2023
What are Natural Killer Cells?
Feb 06, 2023
Different Types of CAR-T in Multiple Myeloma
Oct 26, 2022
What Is the Process of CAR-T Cell Therapy in Myeloma?
Oct 12, 2022
CAR-T Side Effects
Oct 03, 2022
What is CAR-T Cell Treatment in Multiple Myeloma?
Sep 27, 2022